Mine Orlu Gul
University College London School of Pharmacy, UK
Title: Coping with the management of medicine at old age: What older people think? What formulations scientists can do?
Biography
Biography: Mine Orlu Gul
Abstract
The current patient-centric formulation development specifi cally for geriatric patients is limited. However, steps are taken to improve the present status. Th e European Medicines Agency`s Geriatric Medicines Strategy, FDA`s Guidance of Industry E7 Studies in Support of Special Populations: Geriatrics - Questions and Answers document and EFPIA Position Paper on Drug Development for Older and Ageing Patients are promising to increase the availability of medicines tailored for needs of older patients. Th e review of current scientifi c literature shows that further research should be performed to rationalize formulation development for elderly. Besides the conventional biopharmaceutical properties of the drug and quality aspects of the formulation, organoleptic properties such as ease of swallowing, taste and simplicity of opening packaging should be considered at early stage of product development due the potential impact on patient acceptability. The presentation will cover several ongoing scientific studies to explore the pharmaceutical needs and solutions under the light of the opinion of older people obtained during public engagement workshops.
Speaker Presentations
Speaker PPTs Click Here